New Drugs FDA Approves Fycompa for the Treatment of Partial-Onset Seizures in Pediatric Patients as Young as 4 Years Old 6 years ago
New Drugs Eisai Announces FDA Approval of Fycompa in Pediatric Patients as Young as 4 Years Old for the Treatment of Partial-Onset Seizures 6 years ago
Healthcare News Vegetarian Diet Benefits Include Reducing Depression Risk, Study Suggests 6 years ago
Pharma Industry News Strategically Selecting the Best Superficially Porous Particle LC Column for Your Method Development 6 years ago
New Drugs FDA Approves Vizimpro (dacomitinib) for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer 6 years ago